U.S. market Closed. Opens in 6 hours 5 minutes

XRTX | XORTX Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/A
Operating Expenses3.20M9.86M2.86M1.30M565.97K1.16M
Selling, General & Admin3.18M2.29M1.58M1.10M506.17K795.65K
Research & Development3.20M6.49M669.11K277.45K39.90K342.25K
Other Operating ExpensesN/AN/AN/AN/AN/A-2.64M
Operating Income-6.57M-10.69M-4.14M-1.30M-565.97K-1.16M
Other Expenses / Income3.71M3.70M2.84M29.41K-26.40K-2.60M
Before Tax Income-2.86M-6.99M-1.30M-1.28M-629.58K-3.78M
Income Tax Expenses004.39K13.51K37.21K22.30K
Net Income-2.86M-6.99M-1.30M-1.28M-629.58K-3.78M
Interest ExpensesN/AN/A4.39K13.51K37.21K22.30K
Basic Shares Outstanding1.98M1.48M1.09M740.00K595.00K585.00K
Diluted Shares Outstanding1.98M1.48M1.09M740.45K595.49K585.05K
EBITDA-6.47M-10.63M-4.12M-1.28M-546.07K-1.14M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-2.86M-6.99M-1.29M-1.26M-555.15K-3.73M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙